Меню
Набор скоро начнётся NCT07149077

Echo-guided Scalp Blocks and Incidence of Postoperative Pain in Scheduled Supratentorial Intracranial Surgery.

Фаза III С лечением Anesthesia , Analgesia

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Echo-guided scalp blocks, Classic anesthetic strategy.
Кому может быть актуально
Состояния в реестре: Anesthesia , Analgesia. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Франция
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

Up to 30% of patients undergoing intracranial surgery present moderate to severe pain. In this type of surgery, the restriction of the pharmacopoeia, which goes against the concept of multimodal analgesia, results in the important use of opioids not without consequences in terms of complications. Numerous studies have highlighted the benefits of scalp blocks in postoperative pain. The originality of this study lies firstly in the fact that the scalp blocks will be guided by ultrasound and secondly, the incidence of severe pain after scalp blocks will be evaluated

Подробное описание

In neurosurgery, up to 30% of patients experience severe pain (Numeric Pain Rating Scale \> 5) after craniotomy. In order to ensure optimal patient comfort during the perioperative period, multimodal analgesia is the rule. However, the use of certain analgesics in this type of surgery is discussed.

The two analgesics most used in this type of surgery are paracetamol and opioids. The latter, used in large quantities, can lead to an increase in drowsiness, disrupt the postoperative neurological clinical examination (Glasgow score, etc.), cause nausea/vomiting or respiratory depression which will increase complications and the length of stay of patients. Despite the use of morphine and its adverse effects, some study highlighted the high incidence of pain, particularly severe pain in post-craniotomy surgery.

Whether it is to improve postoperative pain or to decrease the intraoperative hemodynamic response, many studies have underlined the interest of scalp block in the postoperative analgesia of craniotomies. Even if large randomized clinical trials are necessary, scalp blocks have been evaluated in subdural hematoma evacuation surgeries, in awake neurosurgeries or in Arnold neuralgia. Intraoperative arterial hypertension induces a risk of increased bleeding and an increase in intracranial pressure with the consequent consequences on cerebral perfusion pressure. These hemodynamic variations, whether intra or post operative, are a source of adverse events.

However, the results of the different studies appear to be discordant and are more interested in the comparison of pain scores and not in the incidence of severe pain. Scalp blocks are mostly performed from anatomical landmarks. In addition, the scalp, which is richly vascularized, is a source of intravascular passage of local anesthetics. Ultrasound-guided scalp blocks are part of this morphine-sparing and multimodal analgesia approach and would allow the realization of a locoregional anesthesia by decreasing, through the use of ultrasound, the risks of intravascular injection and the quantity of local anesthetic.

This study is one of the first to evaluate the impact of an ultrasound-guided scalp block on the incidence of severe postoperative pain (Numeric Pain Rating Scale \> 4) in supratentorial intracranial surgery.

Вмешательства

  • Препарат Echo-guided scalp blocks
    Classic anesthetic strategy in association with echo-guided scalp blocks
  • Препарат Classic anesthetic strategy
    classic anesthetic strategy with postoperative analgesia associating Paracetamol and Morphine with standardized dose.

Первичные конечные точки

  • Intense post-operative pain [Срок оценки: up to 6 hours after extubation (day 0)]
Вторичные конечные точки (5)
  • Absolute pain [Срок оценки: at Day 0, hourly until 6 hours after extubation and 24 hours after intervention]
  • Morphine consumption. [Срок оценки: at Day 0, hourly until 6 hours after extubation and 24 hours after intervention]
  • Incidence of Postoperative nausea and vomiting [Срок оценки: at day 0 : 6 hours and 24 hours after intervention]
  • Chronic post-operative pain [Срок оценки: 3 months after Day 0]
  • Infection [Срок оценки: 3 months after Day 0]

Критерии участия

Критерии включения

  • Patient managed in the neurosurgical unit for supratentorial intracranial surgery.
  • Person affiliated or beneficiary of a social security plan.
  • Free, informed, and written consent signed by the participant and the investigating physician (at the latest on the day of inclusion and before any examination required by the research).

Критерии исключения

  • Surgical procedure under awake surgery (systematic realization of scalp blocks necessary)
  • Aphasia of comprehension preoperatively or expected postoperatively or any other neurological impairment making self-evaluation of pain impossible.
  • Contraindication to the use of local anesthetics: allergy or history of intoxication to local anesthetics
  • Contraindication to adrenaline infiltration: severe ventricular rhythm disorders, severe obstructive cardiomyopathy, unstable coronary insufficiency, hypersensitivity to adrenaline.
  • Chronic pain patient or patient with daily preoperative consumption of morphine
  • Pregnant or breast-feeding woman
  • Patient under legal protection (persons deprived of liberty or under guardianship)

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Лечение

Центры проведения

Франция · 1 центр
  • Bordeaux university hospital — Bordeaux

Идентификаторы

NCT: NCT07149077 · CHUBX 2023/42

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗